«
Tuberculosis (TB) remains a
major global health problem and identifying new
drug targets and candidate
drugs is a
major priority,» said David S. Perlin, Executive Director and Professor at the Public Health Research Institute and Rutgers Regional Biocontainment Laboratory at the International Center for Public Health at Rutgers New Jersey Medical School in Newark.
Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing
drug - resistant forms of
tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a
major threat to global public health.